ABSTRACT. The fbcB and fbcC genes encoding cytochromes b and c 1 of the bc 1 -complex, were extended with a segment to encode a poly-histidine tag linked to their C-terminal sequence allowing a one-step affinity purification of the complex. Constructions were made in vitro in a pUC-derived background using PCR amplification. The modified fbc operons were transferred to a pRK-derivative plasmid, and this was used to transform the fbc -strain of Rhodobacter sphaeroides, BC17. The transformants showed normal rates of growth. Chromatophores prepared from these cells showed kinetics of turnover of the bc 1 -complex on flash activation which were essentially the same as those from wild-type strains, and analysis of the cytochrome complement, spectral and thermodynamic properties by redox potentiometry showed no marked difference from the wild-type. Chromatophores were solubilized and mixed with Ni-NTA Sepharose resin. A modification of the standard elution protocol in which histidine replaced imidazole, increased the activity 20-fold. Imidazole modified the redox properties of heme c 1 , suggesting ligand displacement and inactivation when this reagent is used at high concentration. The purified enzyme contained all four subunits in an active dimeric complex. This construction provides a facile method for preparation of wild type or mutant bc 1 -complex, for spectroscopy and structural studies. 3 The ubiquinol:cytochrome c 2 oxidoreductase (bc 1 -complex ) of Rb. sphaeroides is the central enzyme of the photosynthetic and respiratory electron transfer chains of this bacterium, and performs the same catalytic function as the equivalent enzyme in the mitochondrial respiratory chain. Kinetic studies of the function are more tractable in the photosynthetic bacteria because of the ease with which the reactions can be initiated by flash illumination. A considerable body of work on characterization of modified function in mutant strains and interpretation in terms of mechanism and structure has been reported (see Brasseur et al. (1), for a recent summary). With the recently reported progress in structural characterization of the bc 1 -complex from beef and chicken heart mitochondria (2-4), the field is poised for dramatic advances in our understanding of the interface between structure and function.
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The ubiquinol:cytochrome c 2 oxidoreductase (bc 1 -complex ) of Rb. sphaeroides is the central enzyme of the photosynthetic and respiratory electron transfer chains of this bacterium, and performs the same catalytic function as the equivalent enzyme in the mitochondrial respiratory chain. Kinetic studies of the function are more tractable in the photosynthetic bacteria because of the ease with which the reactions can be initiated by flash illumination. A considerable body of work on characterization of modified function in mutant strains and interpretation in terms of mechanism and structure has been reported (see Brasseur et al. (1) , for a recent summary). With the recently reported progress in structural characterization of the bc 1 -complex from beef and chicken heart mitochondria (2-4), the field is poised for dramatic advances in our understanding of the interface between structure and function.
Protocols for isolation and purification of an active complex have been established, but these have been relatively time consuming, and this has discouraged extensive work on crystallization, detailed spectroscopy and characterization of mutant strains, where these have required substantial concentrations of the complex. In the past few years, simple and rapid protocols using an affinity tag, usually a six histidine repeat on one subunit, have been reported as a means to isolate membrane protein complexes. Several respiratory or photosynthetic enzymes such as cytochrome oxidases (5-7), ATP-synthases (8, 9) , and photosynthetic reaction centers (10, 11) have been successfully isolated from a broad range of organisms using this technique. In this paper we report the construction and expression of two versions of the Rb. sphaeroides bc 1 - complex in which histidine extensions (his-tag) have been added to the C-terminal ends of cyt b and cyt c 1 subunits, respectively. This has allowed the development of protocols for one-step purification of the complex in active form. The presence of the his-tag appears to have no 4 significant effect on the kinetics of turnover of the complex in the photosynthetic chain, nor on the thermodynamic and spectrophotometric characteristics of the complex in situ or after isolation.
However, isolation of an active complex required modification of the protocol for elution of the his-tagged complex, in which histidine was used instead of imidazole.
MATERIALS AND METHODS

Bacteria and Plasmids.
The Escherichia coli strains were grown at 37°C in LB broth. Plasmids pUC9 (GenBank accession number L09128), pT7T319U (GenBank accession number U13870) and their derivatives were maintained in the presence of 100 µg/mL ampicilin, pRK415 (12) and its derivatives with 10 µg/mL tetracycline. Rb. sphaeroides strains were grown in Sistrom medium. This medium was supplied with 10 µg/mL kanamycin when growing the recipient strain BC17 (13) . For all of the derivatives, 2 µg/mL tetracycline was also added in order to maintain the mutant plasmids. Cells were grown either under anaerobic photosynthetic conditions or aerobically. When large volumes of cell culture were needed, Rb. sphaeroides cells were grown in a 20 liter fermentation tank equipped with lights. The temperature was kept at 29° C and nitrogen gas was used to maintain anaerobiosis in the fermentor .
Strategy for the insertion of histidine tag. Prior to the introduction of the his-tag at the Cterminus of either cyt b or cyt c 1 , the 1.9 kb Xcm I-EcoR I DNA fragment of plasmid pBC9 (13) located after the putative transcription termination site of the fbc operon was deleted and replaced by the ECO linker (see Table 1 ). The resulting plasmid, which contains the whole fbc operon without ancillary sequences, was called pGB1 (Fig. 1) . Subsequently, the 2.4 kb Hind III-Bgl II fragment of pGB1 was removed and replaced by the HIND linker ( Table 1) . The Hind III-EcoR I 5 fragment was then subcloned into the pT7T319U cloning vector yielding the pGB2T plasmid. This plasmid contains the end of the fbcB coding frame and the complete sequence of fbcC gene.
In order to introduce the histidine tag sequence at the C-terminus of cyt b, we first introduced an unique Sal I restriction site in place of the fbcB stop codon. To this end, we amplified a 241 bp fragment using the primers BSAL and BRPDOWN, with pGB2T as template.
This PCR product was used as a primer in combination with BGFBCPRUP primer to amplify a 475 bp fragment. This fragment was digested by Bgl II and Pst I and used to replace the original Bgl II-Pst I fragment of pGB2T leading to plasmid pGB3BSAL. The his-tag sequence was introduced by PCR amplification between the primers BGFBLPRUP and BGBPRH6, using pGB3BSAL as a template. The resulting product was digested by Bgl II and Sal I and used to replace the Bgl II-Sal I fragment of pGB3BSAL leading to plasmid pGB10BH6. Primer BGBPRH6 allowed the insertion of both the factor Xa proteolytic site and the hexahistidine motif (see Table 1 ). The factor Xa site provided a way to remove in vitro the histidine tail from the recombinant protein. This feature was not used in our study. Finally the Bgl II-EcoR I fragment of pGB10BH6 was cloned back into pGB1 to yield the complete fbc operon carrying a his-tag sequence fused to the end of the fbcB coding frame. The construction of the fbcC gene carrying the sequence encoding a his-tag was performed using a similar approach. A unique Sal I restriction site was introduced in place of the fbcC stop codon. To this end, we amplified a 216 bp fragment using the primers C1PRUP and C1SALDOWN, with pGB2T as template. This fragment was digested by Aat II and Xma I and used to replace the original Aat II-Xma I fragment of pGB2T leading to plasmid pGB3CSAL. The his-tag sequence was introduced by PCR amplification between the primers C1PRUP and BGCPRH6, using pGB3CSAL as a template. The resulting 6 product was digested by Aat II and Sal I and used to replace the Aat II-Sal I fragment of pGB3CSAL leading to plasmid pGB10CH6. Finally the Bgl II-EcoR I fragment of pGB10CH6 was cloned back into pGB1 to yield the complete fbc operon carrying a his-tag sequence fused to the end of the fbcC coding frame. All PCR products were verified by DNA sequencing. The two mutant fbc operons, carrying the his-tag, were subcloned into pRK415 vector. These constructs were introduced in E. coli strain S17-1 (14) and the property of this E. coli strain to conjugate with Rb. sphaeroides was used to transfer the recombinant plasmids into BC17, a Rb. sphaeroides strain carrying a deletion of the endogenous fbc operon (13) . The Rb. sphaeroides strains carrying the his-tagged cyt b or cyt c 1 were respectively designated BH6 and CH6.
Purification of the his-tagged bc 1 -complex. Rb. sphaeroides cells were collected by 10 min centrifugation at 14000×g, washed once with 50 mM MOPS, pH 7.00, 100 mM KCl (buffer A) and resuspended in buffer A (about 1/150 of the initial culture volume). DNase I and RNase A were added to the suspension at final concentrations of 100 µg/ml and 10 µg/ml, respectively. The cells were disrupted in a French press at 12,800 psi. Unbroken cells were removed by centrifugation at 30,000×g for 30 min. To collect the chromatophores, the supernatant was further centrifuged at 100,000×g for 90 min. The pellet was resuspended in buffer A with 25% glycerol.
The final concentration was adjusted to ∆A 562-577nm = 0.6 and the membrane suspension was stored at -80°C until used. Solubilization of the membranes and binding of the his-tagged bc 1 complex to the Ni-NTA resin (QIAGEN, Inc., Valencia, CA) were carried out simultaneously at 4°C as described below. All following buffers contain 0.2 mM PMSF and 0.1 mM ε-aminocaproic acid as protease inhibitors. 7 One volume of chromatophores (∆A 562-577nm = 0.6) (usually 10 mL) was diluted with 0.3 volumes (3 mL) of buffer B (50 mM MOPS pH 7.8, 100 mM NaCl, 1 mM MgSO 4 with a cut-off of 100,000 Da. When necessary, the histidine was removed by overnight dialysis against 50 mM MOPS pH 7.0, 100 mM NaCl, 1 mM MgSO 4 , 20% (w/v) glycerol, containing 0.01% DM and 15 µg/mL phosphatidyl choline. When dialysis was not performed, the purified complex was mixed with glycerol (20% (w/v)) prior to freezing. Purified bc 1 -complex was frozen in liquid nitrogen and stored at -80°C until used. 8 Estimation of the total molecular weight. The molecular weight of the bc 1 -complex was estimated using an 1.5 cm x 30 cm Ultrogel AcA 34 column (Biosepra, Marlborough, MA) equilibrated with 40 mM Na-phosphate buffer pH 7.0, 50 mM NaCl and 0.02% DM at a flow rate of 0.3 mL/min at 4 °C. A calibration curve was made using β-amylase (2 mg), alcohol dehydrogenase (2 mg), bovine albumin (5 mg) and carbonic anhydrase (2 mg) as molecular weight markers (Sigma). The elution volumes for horse cyt c (2 mg) and thyroglobulin (4 mg) were also determined although they were not used for the calibration curve as they are outside of the linear range specified by the manufacturer for the Ultrogel AcA34. Nevertheless we noticed that the elution volumes of these two polypeptides fitted well the calibration curve. The bc 1 -complex was diluted in the running buffer to a 20 µM concentration and 500 µL samples were loaded on the column.
Optical redox titrations.
Optical spectra were obtained using single-beam spectrophotometer, built in the laboratory (15) and interfaced to a PC-compatible computer for control and storage of the data using a program written in-house (Crofts & Guergova-Kuras, unpublished). Absorbance spectra of chromatophore preparations or purified bc 1 complexes were recorded approximately every 10 mV. The potential was modified by addition of either dithionite (sodium hydrosulfite) or potassium ferricyanide, followed by a 3 to 5 minutes equilibration time. For the b-type cytochromes, the titration was performed over a range from -200 to 250 mV. The titration curves were obtained from the absorbance spectra by abstracting values at 561 nm and 569 nm. The curves were fitted with either 2 or 3 Nernst components using the built-in non-linear square fitting algorithm of the data-analysis program Origin 4.0 (Microcal Software, Inc., Northampton, MA).
The titration curves for cyt c 1 were obtained as the difference of 554 nm and 548 nm from 9 absorption spectra taken in the redox region of 0 to 400 mV and were fitted to Nernst components using the same fitting algorithm.
Flash-induced kinetics. The flash-induced absorbance changes of the bc 1 -complex and the reaction center were monitored on a single-beam spectrophotometer in a redox cuvette as previously described (16). Kinetics of the reaction center were followed at 542 nm, of the combined cyt c 1 and c 2 at 551nm minus 542 nm, the cyt b H changes were monitored as the difference between 561 nm and 569 nm (13, 15, 16) .
EPR measurements. EPR spectra were obtained using a Bruker 220D X-band spectrometer equipped with a liquid-helium system Bruker ESP-300. The conditions used were: microwave frequency 9.45 GHz, microwave power 2 mW, modulation amplitude 12.5 G, time constant 0.3 s, temperature 8 K.
Miscellaneous.
SDS-PAGE analysis was carried out in a SDS-12.5% polyacrylamide gel (SDSpolyacrylamide gel system, Gibco BRL Life Technologies, Gaithersburg, MD) with a running buffer containing 49 mM Tris, 384 mM glycine, and 0.1% (w/v) SDS, pH 8.5). Coomassie blue staining was used for detection of the polypeptides.
Protein determinations were made according to the method of Lowry modified by Peterson (17) using bovine serum albumin as a standard. (Sigma, protein assay kit).
The concentrations of cyt b and cyt c 1 in the purified complex were measured from reduced minus oxidized difference spectra as described by Vanneste (18) Ubiquinol:cytochrome c oxidoreductase activity was assayed using 25 µM horse cyt c as an electron acceptor and 100 µM decylubiquinol (Sigma) as an electron donor (19) . The reaction was initiated by adding decylubiquinol to the reaction mixture containing 50 mM Tris-HCl pH 8.0
, 100 mM NaCl, 0.01% DM, 15 µg/mL phosphatidyl choline, 25 µM horse cyt c and 30 nM bc 1 complex. The reduction of horse cyt c was monitored at 549 nm and an extinction coefficient of 22 000 M -1 .cm -1 was used (20) .
Extraction and HPLC analysis of the quinone content of the purified complex was performed as in Kroger (21) . sphaeroides BC17C (13), a strain where the deletion of the genomic fbc operon was complemented in trans by an extrachromosomal fbc operon cloned into the pRK415 vector.
RESULTS
Purification
For most purifications, the starting material was a chromatophore suspension prepared from bacteria grown anaerobically under light. The same procedure was also used successfully to isolate the complex from membrane fragments from bacteria grown under aerobic conditions, in which respiratory mode of growth was used. An important parameter for both the yield of recovery and the activity of the purified enzyme was the concentration of the bc 1 -complex during the solubilization/binding step. Since the amount of the resin is estimated from a binding capacity of 7
mg bc 1 -complex/mL resin, which is in the range specified by the manufacturer, the concentration of the bc 1 -complex will determine the ratio of the resin volume to the total volume. Using a simple trial and error method we estimated that the optimal ratio is at 17% (by vol.). The amount of detergent was then estimated to give a final ratio of 0.66 mg DM/mg total protein. In the following steps the detergent concentration was decreased to 0.01% (w/v) DM since high concentrations of detergent during the column washing lead to the loss of the [Fe-S] protein and the subunit IV. A similar effect was observed when the elution step was performed in the absence of phosphatidyl choline; apart from preliminary characterization, we did not investigate this further. 12 An important modification of the protocols supplied by the manufacturer for purification of his-tagged proteins using the Ni-nitrilotriacetic acid resin was to replace imidazole with histidine.
This substitution allowed us to increase the activity of the preparations from 5 mol cyt c. preparations obtained using histidine (see Table 2 ). A probable reason for the low activity of the bc 1 -complex in the presence of imidazole will be discussed later in the text. Fig. 4 shows a symmetrical elution peak which corresponds to a particle with a molecular weight of 260 kDa. Taking into account the molecular weight of the detergent micelles, this value corresponds to the presence of two copies of each of the four subunits of the bc 1 -complex and therefore to a dimeric state of the enzyme in our preparations. purified bc 1 -complex was 1.9 whether it was calculated from reduced-oxidized difference spectra 14 of the purified preparation or, under denaturing conditions, from heme assays with alkaline pyridine. Similar data have been reported for the wild-type bc 1 -complex (22, 23, 25) . The EPR spectra of the dithionite-reduced Rieske center from bc 1 -complexes isolated from both the BH6 and the CH6 strains were similar to the WT (26) with g values of 1.76, 1.90 and 2.02.
Potentiometric titrations. The midpoint potentials of the cytochromes in both chromatophores
and purified complexes are listed in Table 3 . The presence of a histidine tag on either of the subunits of the complex (cyt b or cyt c 1 ) had little effect on the E m,7 values of all three hemes as compared to the WT. Titrations of cyt c 1 in preparations obtained using imidazole in the purification procedure provided an explanation for the low activity of these preparations (see above). We observed that while 30% of cyt c 1 retained a mid-point potential comparable to the value found for highly active bc1 complex (250-270 mV), 70% showed a lower mid-point potential of 146±6 mV. It has been shown that imidazole can displace the methionine axial heme iron ligand of cyt c (27) and that this type of ligand substitution is accompanied by a decrease in the mid-point potential of the heme (28). We suggest therefore that a similar ligand substitution occurs in cyt c 1 of the bc 1 -complex when imidazole is used in the purification procedure. 
DISCUSSION
Our purification protocol combines a biochemical approach where a non-ionic detergent is used for solubilizing membranes from Rb. sphaeroides with a molecular biology approach which extend one of the subunits of the complex with an affinity tag, allowing us to isolate the bc 1 -complex with a high-specificity. The affinity tag, six additional histidines at the C-terminus of either cyt b or cyt c 1 , via a highly specific binding to a Ni-nitrilotriacetic acid resin allows us to recover the bc 1 -complex from membrane preparations using a fast and simple 'one-step' purification procedure.
Our results indicate that the his-tag does not modify the properties of the complex in situ as shown by the spectral, redox and electron transfer properties of the bc 1 -complex. Moreover, none of the complex takes only 4 hours to perform. Moreover our average yield of recovery is greater than 50%, at least 4 times higher than the previously reported values (22, 23) . We have also successfully applied this purification method to isolate bc 1 -complex from mutant strains of Rb.
sphaeroides bearing the his-tag and additional mutations in the fbc operon (unpublished results). Table 3 . Mid-point potentials of the cytochromes from the bc 1 -complex.
All the redox titrations were made in 50 mM Mops pH 7, 100 mM KCl, and Restriction sites are indicated only when they are unique in the plasmid. wavelength, nm
